Antihypertensive Therapy with MK 4211

Publisher Website
Google Scholar
Abstract
Nineteen hypertensive patients were treated with increasing doses of the new angiotensin-converting enzyme inhibitor MK 421. Twenty milligrams orally reduced blood pressure from 180/112 ± 6.8/3.6 (mean ± SEM) to 160/100 ± 6.5/3.3 mm Hg (p